ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

NVCT vs OLMA // ENTERPRISE SCALE & MARKET CAP

Nuvectis Pharma Inc. (NASDAQ) VS. Olema Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: NVCT 2 — OLMA 2
▲ ENTERPRISE SCALE & MARKET CAP LEADER: OLMA
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NVCT VS. OLMA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC NVCT OLMA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -32.80% -2.20 OLMA /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -2.64% -22.88% +20.24 NVCT /fcf-yield <GO>
Operating Margin — — — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 2/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 41.5 41.3 +0.20 NVCT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $602.7M $612.5M -$9.8M OLMA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR NVCT REV OLMA REV NVCT GROSS % OLMA GROSS % NVCT FCF OLMA FCF
FY 2025 $77.2M $500.4M — — -$16.0M -$146.7M
FY 2024 $55.6M $398.3M — — -$12.2M -$104.5M
FY 2023 $64.1M $293.9M — — -$16.0M -$83.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NVCT // BETA —
OLMA // BETA —